[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575623":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":32,"collaborators":7,"id":34,"slug":35,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":7,"eligibilityCriteria":39,"healthyVolunteers":36,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Cristina Mosconi, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","0039 3498496325","cristina.mosconi@aosp.bo.it",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":21,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"RECRUITING","Bologna","40138","Italy","IT",{"type":25,"coordinates":26},"Point",[27,28],11.33875,44.49381,{"lat":28,"lon":27},[31],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100575623","intra-artherial-therapies-in-treatment-of-primary-liver-diseases-an-observational-study-100575623",false,"NCT06774690","Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study","Inclusion Criteria:\n\n* diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments:\n\n  * Trans-arterial embolization (TAE),\n  * Transarterial chemoembolization (TACE),\n  * Transarterial radioembolization (TARE)\n  * Drug-eluting beads chemoembolization (DEB-TACE)\n* Age over 18\n* To give informed consent\n\nExclusion Criteria:\n\n* shunt of gastro intestinal arteries that cannot be embolized\n* metastasis spread outside of the liver\n* liver failure","ALL","18 Years",{"count":43,"type":44},3300,"ESTIMATED","9 Years","OBSERVATIONAL","The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer.\n\nIntra arterial therapies are radiologic procedures that block liver cancer blood supply.\n\nThe researchers will collect the data of participants located in the Radiology department in \"IRCCS Azienda Ospedaliera Universitaria\" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.",[49,50],"HCC - Hepatocellular Carcinoma","Cholangiocarcinoma Cancer","2025-01-09",{"date":53,"type":54},"2025-01-14","ACTUAL",{"date":56,"type":54},"2021-04-21",{"date":58,"type":44},"2030-04",{"name":5,"class":6},1]